Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 314 participants.
Also called NCT07902791
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 314 participants
- Registry
-
NCT07902791
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07902791. Randomized; single masking; primary purpose treatment. Start 2026-06-22 (actual); primary completion 2029-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy
- Acronym
- SAVE
- Condition
- Acute Ischemic Stroke
- Condition
- Large Vessel Occlusion
- Intervention (Drug)
- Sevoflurane
- Intervention (Drug)
- propofol (drug)
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Record details
- Record id
cardio:ct-nct07902791- Content hash
18692bd24e9aff1d3a7674fd3ccddc09184bd4c458a00fec21212ec57c66b162